FIGARO-DKD
Phase III study
Phase III FIGARO-DKD study in patients with chronic kidney disease and type 2 diabetes
The finerenone phase III clinical trial programme comprises the FIDELIO-DKD and FIGARO-DKD studies, and is the largest of its kind to date
FIDELIO-DKD and FIGARO-DKD are investigating complementary kidney and heart outcomes. 7,8
